Growth Metrics

Labcorp Holdings (LH) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Labcorp Holdings (LH) over the last 11 years, with Q3 2025 value amounting to $391.6 million.

  • Labcorp Holdings' Current Deferred Revenue fell 285.29% to $391.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.6 million, marking a year-over-year decrease of 285.29%. This contributed to the annual value of $392.2 million for FY2024, which is 699.55% down from last year.
  • Latest data reveals that Labcorp Holdings reported Current Deferred Revenue of $391.6 million as of Q3 2025, which was down 285.29% from $398.0 million recorded in Q2 2025.
  • In the past 5 years, Labcorp Holdings' Current Deferred Revenue ranged from a high of $593.9 million in Q3 2021 and a low of $310.6 million during Q4 2022
  • Over the past 5 years, Labcorp Holdings' median Current Deferred Revenue value was $403.1 million (recorded in 2024), while the average stood at $454.7 million.
  • As far as peak fluctuations go, Labcorp Holdings' Current Deferred Revenue tumbled by 4438.68% in 2022, and later surged by 3576.95% in 2023.
  • Over the past 5 years, Labcorp Holdings' Current Deferred Revenue (Quarter) stood at $558.5 million in 2021, then crashed by 44.39% to $310.6 million in 2022, then soared by 35.77% to $421.7 million in 2023, then fell by 7.0% to $392.2 million in 2024, then decreased by 0.15% to $391.6 million in 2025.
  • Its last three reported values are $391.6 million in Q3 2025, $398.0 million for Q2 2025, and $388.3 million during Q1 2025.